MTOR and cancer: Since mTOR inhibitor- induced eIF4E phosphorylation is PI3K and Mnk dependent, one strategy to improve an mTOR inhibitor’s efficacy against cancer is to prevent eIF4E phosphorylation by combining an mTOR inhibitor with a PI3K inhibitor or a Mnk inhibitor.